GH Research to Present at Cantor Global Healthcare Conference
Ticker: GHRS · Form: 6-K · Filed: Aug 29, 2025 · CIK: 1855129
Sentiment: neutral
Topics: conference-participation, investor-relations
TL;DR
GH Research is hitting the Cantor Healthcare Conference Sept 3-5 in NYC for investor chats.
AI Summary
GH Research PLC announced its participation in the Cantor Global Healthcare Conference, scheduled for September 3-5, 2025, in New York. The company will engage in a fireside chat and conduct one-on-one investor meetings during the event.
Why It Matters
This conference provides GH Research an opportunity to engage with investors and present its latest developments, potentially influencing its stock valuation.
Risk Assessment
Risk Level: low — This filing is a routine announcement of participation in a conference, with no material financial or operational changes disclosed.
Key Players & Entities
- GH Research PLC (company) — Registrant
- Cantor Global Healthcare Conference (company) — Event
- September 3-5, 2025 (date) — Conference dates
- New York (location) — Conference location
FAQ
What is the purpose of GH Research PLC's participation in the Cantor Global Healthcare Conference?
GH Research PLC will participate in a fireside chat and hold one-on-one investor meetings during the conference.
When and where will the Cantor Global Healthcare Conference take place?
The conference is scheduled to take place from September 3-5, 2025, in New York.
What type of report is this filing?
This filing is a Form 6-K, Report of Foreign Private Issuer.
What is GH Research PLC's principal executive office address?
The principal executive office is located at Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland.
Does GH Research PLC file annual reports under Form 20-F or Form 40-F?
GH Research PLC files annual reports under Form 20-F.
Filing Stats: 175 words · 1 min read · ~1 pages · Grade level 14.7 · Accepted 2025-08-29 07:00:20
Filing Documents
- ef20054852_6k.htm (6-K) — 7KB
- 0001140361-25-033290.txt ( ) — 8KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2025. Commission File Number: 001-40530 GH Research PLC (Exact name of registrant as specified in its charter) Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F GH Research PLC will participate in a fireside chat and hold one-on-one investor meetings during the Cantor Global Healthcare Conference, which is scheduled to take place from September 3-5, 2025, in New York. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: August 29, 2025 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance 2